G1 Therapeutics Debt to Equity Ratio 2016-2024 | GTHX
Current and historical debt to equity ratio values for G1 Therapeutics (GTHX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. G1 Therapeutics debt/equity for the three months ending June 30, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $0.07B | $0.03B | 3.01 |
| 2024-03-31 | $0.07B | $0.03B | 2.68 |
| 2023-12-31 | $0.09B | $0.04B | 2.44 |
| 2023-09-30 | $0.09B | $0.04B | 2.09 |
| 2023-06-30 | $0.09B | $0.06B | 1.57 |
| 2023-03-31 | $0.12B | $0.05B | 2.60 |
| 2022-12-31 | $0.12B | $0.07B | 1.73 |
| 2022-09-30 | $0.12B | $0.05B | 2.62 |
| 2022-06-30 | $0.12B | $0.07B | 1.82 |
| 2022-03-31 | $0.12B | $0.10B | 1.18 |
| 2021-12-31 | $0.11B | $0.14B | 0.77 |
| 2021-09-30 | $0.07B | $0.18B | 0.37 |
| 2021-06-30 | $0.06B | $0.21B | 0.30 |
| 2021-03-31 | $0.06B | $0.25B | 0.26 |
| 2020-12-31 | $0.05B | $0.18B | 0.29 |
| 2020-09-30 | $0.06B | $0.20B | 0.31 |
| 2020-06-30 | $0.05B | $0.20B | 0.24 |
| 2020-03-31 | $0.03B | $0.23B | 0.12 |
| 2019-12-31 | $0.03B | $0.26B | 0.12 |
| 2019-09-30 | $0.03B | $0.29B | 0.11 |
| 2019-06-30 | $0.02B | $0.31B | 0.06 |
| 2019-03-31 | $0.01B | $0.34B | 0.04 |
| 2018-12-31 | $0.01B | $0.36B | 0.04 |
| 2018-09-30 | $0.01B | $0.38B | 0.04 |
| 2018-06-30 | $0.01B | $0.18B | 0.08 |
| 2018-03-31 | $0.01B | $0.18B | 0.07 |
| 2017-12-31 | $0.01B | $0.09B | 0.13 |
| 2017-09-30 | $0.01B | $0.11B | 0.10 |
| 2017-06-30 | $0.01B | $0.12B | 0.08 |
| 2017-03-31 | $0.00B | $0.00B | 0.00 |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | $0.00B | 0.00 |
| 2016-06-30 | $0.00B | $0.00B | 0.00 |
| 2015-12-31 | $0.00B | $0.00B | 0.00 |
